|
PLEKHA8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.444350E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.158550E-04 |
| Normal-vs-Stage2 |
9.668400E-02 |
| Normal-vs-Stage3 |
2.918100E-03 |
| Normal-vs-Stage4 |
5.76230000000066E-05 |
| Stage1-vs-Stage2 |
1.263610E-01 |
| Stage1-vs-Stage3 |
9.207400E-01 |
| Stage1-vs-Stage4 |
1.102400E-01 |
| Stage2-vs-Stage3 |
2.555800E-01 |
| Stage2-vs-Stage4 |
2.359900E-02 |
| Stage3-vs-Stage4 |
1.863650E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.822000E-04 |
| Normal-vs-AfricanAmerican |
4.357800E-02 |
| Normal-vs-Asian |
7.68030000000142E-05 |
| Caucasian-vs-AfricanAmerican |
5.406600E-01 |
| Caucasian-vs-Asian |
1.630820E-01 |
| AfricanAmerican-vs-Asian |
1.477610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.75699999999913E-05 |
| Normal-vs-Female |
4.432000E-04 |
| Male-vs-Female |
5.270400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.429300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.622280E-04 |
| Normal-vs-Age(61-80Yrs) |
2.861600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.524800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.022000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.961200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.607000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.719000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.688200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.100800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.584500E-02 |
| Classical-VS-Follicular |
1.323240E-01 |
| Classical-VS-Other |
1.020250E-03 |
| Classical-VS-Normal |
2.159100E-03 |
| Tall-VS-Follicular |
3.953200E-01 |
| Tall-VS-Other |
1.435760E-01 |
| Tall-VS-Normal |
1.592070E-04 |
| Follicular-VS-Other |
1.123810E-02 |
| Follicular-VS-Normal |
5.620500E-04 |
| Other-VS-Normal |
1.55059999995544E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.298920E-03 |
| Normal-vs-N1 |
2.196100E-03 |
| N0-vs-N1 |
3.397600E-01 |
|
|
